Nasal desmopressin (DDAVP, Stimate, etc) is no longer approved for bedwetting
January 2008
See updated information on this topic from Health Canada
Nasal desmopressin (DDAVP, Stimate, etc) is no longer approved for bedwetting...due to reports of serious hyponatremia.
Most of these cases occur in children using the nasal formulations for bedwetting...probably because dosing errors are more common with the nasal form than the tablets.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote